Bioinformatic approaches for identification and characterization of olfactomedin related genes with a potential role in pathogenesis of ocular disorders. by Mukhopadhyay, A. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/57636
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
 Molecular Vision 2004; 10:304-14 <http://www.molvis.org/molvis/v10/a39>
Received 11 December 2003 | Accepted 20 April 2004 | Published 20 April 2004
 Eye and vision research provides a unique opportunity
for bioinformatics studies. The small amount of different tis-
sue types within the eye makes it very difficult to work with
the mRNAs to decipher the complex pathways and the inter-
play of proteins. For example, trabecular meshwork (TM) tis-
sue is the most important part of the eye for studies on the
pathogenesis of primary open angle glaucoma (POAG), but it
forms a very small part of the eye. Hence, it is often very
difficult to have pure TM cells free from contamination of
other types of cells. In public databases like GeneCards, where
tissue specific expression of the genes are recorded, nothing
is mentioned about the expression levels of genes in eye tis-
sues. The lack of information about the tissue-specific expres-
sion of eye proteins dictates the need for an in silico approach
to understand eye diseases at the molecular level. The Na-
tional Eye Institute has made a considerable effort to cata-
logue the genes expressed in different tissues in the eye coupled
with the informatics tools. The aim of the (NEIBank) project
is to use cDNA libraries that represent as closely as possible
the transcript profile of the specialized tissues of the eye. While
cultured cells can be powerful experimental tools it is clear
that they differ significantly from the tissue from which they
were derived [1]. As just one of many known examples (both
published and unpublished), MHC gene expression seems to
be absent in intact lens but is present in cultured lens cells that
are used as models for the lens [2].
A major effort has been made to use bioinformatics to
assemble, organize, and present the NEIBank EST data, to
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Purpose: To identify olfactomedin domain containing proteins, which are expressed in the eye and have similarity to
myocilin, to test as potential candidates for eye diseases. Most of the mutations in myocilin causing primary open angle
glaucoma are located in the olfactomedin domain. In vitro experiments demonstrated interaction between optimedin and
myocilin through the conserved olfactomedin domains of the proteins in rats, and it was speculated that optimedin might
have a role in the pathogenesis of ocular disorders. Hence, we aimed to identify myocilin related human proteins having
conserved olfactomedin domains with potential to interact between them and examine the expression patterns in the eye
by bioinformatics approaches. This endeavor would have the potential to identify new candidate genes for eye diseases in
general and glaucoma in particular to be tested by wet-lab experiments.
Methods: Proteins with homology to myocilin were selected by BLASTp at the NCBI server. cDNA sequences and
corresponding genomic contigs were retrieved. Pairwise BLAST was done to investigate the gene structure. The human
EST database and NEIBank were searched against the selected cDNAs to look for tissue specific expression of the tran-
scripts.
Results: The study led to the identification of three groups of proteins encoded by three different genes; Noelin 1 (9q34.3),
Noelin 2 (19p13.2), and Noelin 3 (1p22) encompassing 45,575 bp, 82,679 bp, and 1,93,421 bp of the genomic sequence,
respectively. Genomic structures, alternate usage of exons, and molecular evolution of the Noelins were determined.
Similar structures of the genes, splicing patterns and high levels of homology shed light on the relatedness and molecular
evolution of this group of olfactomedin related proteins. Strikingly, however, Noelin 1 and Noelin 3 were found to be
expressed as multiple splice variants while only a single spliced transcript could be identified for Noelin 2. A human EST
database search suggested the expression of all three Noelin genes in the brain but only two (Noelin 1 and Noelin 2) in the
eye despite experimental evidence for expression of Noelin 3 in ocular tissue. Myocilin was determined to have similar
levels (60-61%) of homology with all three Noelin gene products (Noelin 1_v1, Noelin 2_v1, and Noelin 3_v1) at the
conserved olfactomedin domains.
Conclusions: Mammalian Noelin 1 evolved from its precursor, followed by evolution of Noelin 3 and Noelin 2 by gene
duplication events. Myocilin might have evolved from Noelin 2 by gene duplication followed by exon fusion. Noelin 1
and Noelin 2 could be tested as candidate genes for eye diseases based on their expressions in the eye and shared olfactomedin
domains with Myocilin in the C-termini of the respective proteins.
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identify and group the high quality sequences, and to remove
the various classes of poor quality, non-mRNA contaminants
and chimeric clones. This has evolved into a rules-based pro-
cedure named GRIST (GRouping and Identification of Se-
quence Tags) [3] that uses sequence matches generated by
BLAST programs [4] and extracts information from GenBank,
UniGene, and other databases. The effort resulted in identifi-
cation of large non-redundant transcripts, novel genes and
splice variants [1,3,5-8]. In a recent effort as part of the
NEIBank project, the characterization of gene expression pat-
terns in the human trabecular meshwork and identification of
the candidate genes for glaucoma was attempted and 3,459
independent TM expressed clones were obtained [9]. These
clones were grouped in 1,888 clusters, potentially represent-
ing individual expressed genes. Transcripts for the myocilin
gene formed the third most abundant cluster in the TM collec-
tion and several other genes implicated in glaucoma (PITX2,
CYP1B1, and optineurin) were also represented. Many other
novel genes were also identified in this effort to elucidate the
molecular mechanisms involved in glaucoma and other TM
diseases [9]. In the context of the vast opportunities in vision
research that have been created by the human genome sequence
and the bioinformatic tools, attempts were made in this manu-
script to identify myocilin related olfactomedin family genes.
Olfactomedins are secreted polymeric glycoproteins of
unknown function with evolutionarily conserved C-terminal
motifs. Olfactomedin was originally identified as the major
component of the mucus layer that surrounds the chemosen-
sory dendrites of olfactory neurons [10]. Homologues were
subsequently also found in other tissues, including the brain,
and in species ranging from Caenorhabditis elegans to Homo
sapiens [11,12]. The molecular evolution of olfactomedin has
also been studied by examining its phylogenetic history to
identify conserved structural motifs. A study based on the com-
parison of protein sequences revealed that the evolution of the
N-terminal half of the molecule involved extensive insertions
and deletions while the C-terminal region evolved mostly
through point mutations, suggesting evolutionary constrains
in the C-terminal region for a predictably important functional
role [12].
The first link between an olfactomedin related protein and
a human disease was established by the discovery in 1997
that defects in myocilin caused POAG [13]. Myocilin was
originally described as a myosin-like acidic protein (isoelec-
tric point 5.2) expressed predominantly in the photoreceptor
cells of the retina and localized particularly in the rootlet and
basal body of the connecting cilium, hence the protein was
named myocilin [14]. Polansky et al. [15] identified the same
protein while studying the effects of steroids on trabecular
meshwork cells in culture. In the eye, the trabecular mesh-
work cells help regulate eye pressure by controlling the drain-
age of fluid from the eye as new fluid is produced. The cul-
tured cells, when treated with steroids, secreted the same pro-
tein which Nguyen et al. [16] called TIGR (for trabecular
meshwork inducible glucocorticoid response protein).
Myocilin is exclusively found in mammals and it has an evo-
lutionarily conserved olfactomedin-like domain in its C-ter-
minal region, including it in the family of olfactomedin-like
proteins.
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TABLE 1. DIFFERENT ISOFORMS OF “MYOCILIN RELATED” PROTEINS
                                          Length     Accession number
Name of the protein in the    Proposed    (amino   ---------------------                     Chromosomal
 database and literature        name      acids)    Protein      cDNA        Exon usage       location
--------------------------   ----------   ------   ---------   ---------   ---------------   -----------
Noelin 1 group of proteins
Pancortin-1                  noelin 1_v1   467     NP_055094   NM_014279   1-5-6-8-9-10
N/A                          Noelin 1_v2   458     BAC04756    AK096304    3-5-6-8-9-10       NT_019501
Noe 1/Noelin precursor/      Noelin 1_v3   485     Q99784      N/A         4-5-6-8-9-10       (9q34.3)
Olfactomedin 1
Pancortin-2/OLFM1            Noelin 1_v4   135     NP_006325   NM_006334   1-5-6-7
Pancortin-3                  Noelin 1_v5   169     NP_478106   NM_058199   1-2
Noelin 2 group of proteins
Noelin 2/Olf C/OLFM2         noelin 2_v1   454     NP_477512   NM_058164   1-2-3-4-5-6        NT_011295
                                                                                              (19p13.2)
Noelin 3 group of proteins
Noe3-3/Optimedin A           noelin 3_v1   458     AAK97475    AF397394    1-4-5-6-8-9
Noe3-1/Optimedin B/          Noelin 3_v2   478     AAK97473    AF397392    3-4-5-6-8-9
OLFM3
Noe3-5                       Noelin 3_v3   383     AAK97477    AF397396    1-2-4-5-6-8-9      NT_028050
Noe3-4                       Noelin 3_v4   215     AAK97476    AF397395    1-4-5-6-7-8-9      (1p22)
Noe3-2                       Noelin 3_v5   235     AAK97474    AF397393    3-4-5-6-7-8-9
Noe3-6                       Noelin 3_v6   140     AAK97478    AF397397    1-2-4-5-6-7-8-9
The annotated gene structures and different splice variants are available in the Third Party annotation database at NCBI (BK001427, BK001428,
BK001429). The proposed names were chosen using the 2002 nomenclature guidelines of the Human Genome Organization. In the “Exon
usage” column, the exon numbers correspond to those in Figure 3. The designation “N/A” indicates the information was not available.
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Mutations in the Myocilin gene have been associated with
3-4% in all POAG cases and a major portion of juvenile open
angle glaucoma (JOAG) in different populations [13,17].
About 50 different mutations have been detected in different
population groups, summarized in a recent review [18]. Un-
fortunately, the pathogenesis of the disease continues to elude
us. Adult onset POAG is also inherited as a non-Mendelian
trait, whereas juvenile onset POAG exhibits mostly autoso-
mal dominant inheritance [19]. It has been observed that among
the 3 exons of Myocilin, the majority of mutations (90%) are
clustered in exon 3 while a few (10%) are located in exon 1
and none in exon 2. We have recently proposed that mamma-
lian myocilin carries the signatures of two different primor-
dial proteins, myosin-like and olfactomedin-like, that may have
been fused in the course of evolution after arthropods to pro-
duce MYOC [20].
Like myocilin, another olfactomedin-like protein,
optimedin, is expressed in the combined tissues of the eye
angle (i.e., trabecular meshwork, iris, and ciliary body), the
retina, and the brain of rats [21]. In human, this protein has
been reported to be expressed in the trabecular meshwork and
neural retina based on RT-PCR analysis [21]. In vitro experi-
ments demonstrate interaction between optimedin and
myocilin through the conserved olfactomedin domain in rats
[21], and there has been speculation that optimedin might have
a role in eye pathogenesis. This observation prompted us to
investigate the olfactomedin-like protein, with homology to
myocilin and expressions in the eye, as potential candidates
for eye diseases. Since glaucoma is transmitted as a mono-
genic disorder as well as a complex disease, the candidate genes
could be examined for the causation of the disease either sin-
gly or in combination with other candidates. It is worth men-
tioning that recently a “digenic” form of glaucoma [22] and a
“tri-allelic” form of Bardet-Biedl Syndrome have been reported
[23].
Here we have identified proteins with high levels of ho-
mology with mammalian myocilin, examined evolutionary re-
lationship between these proteins, determined structures of the
genes, characterized the splice variants and their relative ex-
pression levels by the analysis of the EST database, and dis-
cussed possible roles of these olfactomedin related proteins in
pathogenesis of ocular disorders.
METHODS
Identification of human proteins that have sequence homol-
ogy to myocilin:  Human myocilin (NP_000252) was used as
query and the human protein database was searched by
BLASTp [4] at the NCBI server to identify proteins that have
sequence homology to the query. A total 119 hits were found.
We individually aligned each of these proteins with myocilin
and selected those which had an olfactomedin domain in the
C-terminal region similar to myocilin and homology with
myocilin extending beyond the conserved olfactomedin do-
main. We called these proteins “myocilin related”. We excluded
all the truncated protein entries which did not have either the
start or stop codons defined, and the much larger lathrophilin
group of proteins harboring an olfactomedin region at the N-
terminal instead of the C-terminal region (lectomedin
[NP_056051], lathrophilin [NP_036434], and others) [24]. The
total number of proteins and corresponding cDNAs that were
selected for further analysis are summarized in Table 1.
Phylogenetic analyses of human myocilin, noelin 1_v1,
noelin 2_v1, and noelin 3_v1:  Phylogenetic analysis of the
amino acid sequences of myocilin, noelin 1_v1, noelin 2_v1,
and noelin 3_v1 was carried out at the DDBJ server. The se-
quences were aligned using the multiple alignment tool
ClustalW [25]. An unrooted phylogenetic tree was estimated
using the BLOSUM matrix [26] and the neighbor-joining tree-
building algorithm [27]. Bootstrap values based upon 1,000
iterations provided estimates of statistical support for the tree.
We also compared the relative homology between three noelins
mentioned above (noelin 1_v1, noelin 2_v1, and noelin 3_v1)
and myocilin by pairwise BLAST [28].
Pairwise BLAST and sequence analysis for determina-
tion of gene structure:  The nucleotide links corresponding to
the different protein entries in the database were searched for,
and the corresponding cDNA sequences as well as the genomic
contig were retrieved for further analysis. Pairwise BLAST
[28] was done for the genomic sequences with each of the
cDNAs using appropriate accession numbers as identifiers.
By comparing the co-ordinates of the “query” and the “sub-
ject” in the output data where homology was observed, the
location and size of the coding sequence (exons) were deter-
mined. The intervening sequences in the genome between two
adjacent exons, with no homology with the “query” cDNA,
represented the introns. Within each of the putative introns
the splice junctions (i.e., GT and AG at the 5' and 3' ends of
the DNA fragment, respectively) were identified to ensure that
genomic DNA fragment truly represented an intron.
Parallel to determining manually the structures of the
Noelin genes and usage of alternate exons in the splice vari-
ants, we examined the quality of the same set of data avail-
able from the relevant web sites ENSEMBL and NCBI
AceView. Collating the data from these sites would have been
more efficient. However, we found errors in the data from
both sites, some of which included (but not limited to) the
following: (a) In ENSEMBL, the splice variant noelin 1_v2
does not exist. (b) In AceView there are five different isoforms
for noelin 2 among which, except for the “a” form correspond-
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TABLE 2. RELATIVE HOMOLOGY BETWEEN “MYOCILIN RELATED”
PROTEINS
                MYOC      noelin 1_v1  noelin 2_v1  noelin 3_v1
             ----------   ----------   ----------   ----------
MYOC            100       32 51 (6)    31 47 (13)   30 49 (13)
noelin 1_v1                  100       59 77  (0)   64 80  (0)
noelin 2_v1                               100       61 75  (0)
noelin 3_v1                                            100
The values refer to percent identity (red), positives (green), and gaps
(in parentheses) of amino acids. The gaps introduced to maximize
homology is shown as “0” value when less than 1% (default setting
in pairwise BLAST program in the NCBI server). Positives include
conservative changes of amino acids.
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Noelin l_v1   ----MPGRWRWQRDMHPARKLLSLLFLILMGTELTQVLPTNPEESWQVYSSAQDSEGRCI   56
Noelin 3_v1   --------------MQATSNLLNLLLLSLFAGLDPSKTQISPKEGWQVYSSAQDPDGRCI   46
Noelin 2_v1   --------------MWPLT-VPPPLLLLLCSGLAGQTLFQNPEEGWQLYTSAQAPDGKCI   45
Myocilin      MRFFCARCCSFGPEMPAVQLLLLACLVWDVGARTAQLREANDQSGRCQYTFSVASPNESS   60
                            *  .  :    ::   .    .    . :..   *: :  . ...
Noelin l_v1   CTVVAPQQTMCS------------RDARTKQLRQLLEKVQNMSQSIEVLDRRTQRDLQYV   104
Noelin 3_v1   CTVVAPEQNLCS------------RDAKSRQLRQLLEKVQNMSQSIEVLNLRTQRDFQYV    94
Noelin 2_v1   CTAVIPAQSTCS------------RDGRSRELRQLMEKVQNVSQSMEVLELRTYRDLQYV    93
Myocilin      CPEQSQAMSVIHNLQRDSSTQRLDLEATKARLSSLESLLHQLTLDQAARPQETQEGLQRE   120
              *.                       :. . .* .* . ::::: .  .   .* ..:*
Noelin l_v1   EKMENQMKG-LESKFKQVEESHKQHLARQFKAIKAKMDELRPLIPVLEEYKADAKLVLQF   163
Noelin 3_v1   LKMETQMKG-LKAKFRQIEDDRKTLMTKHFQELKEKMDELLPLIPVLEQYKTDAKLITQF   153
Noelin 2_v1   RGMETLMRS-LDARLRAADGS---LSAKSFQELKDRMTELLPLSSVLEQYKADTRTIVRL   149
Myocilin      LGTLRRERDQLETQTRELETAYSNLLRDKSVLEEEKKRLRQENENLARRLESSSQEVARL   180
                     :. *.:: :  :              : :         : .. ::.:: : ::
Noelin l_v1   K----EEVQNLTSVLNELQEEIGAY-----DYDELQSRVSNLEER----------LRACM   204
Noelin 3_v1   K----EEIRNLSAVLTGIQEEIGAY-----DYEELHQRVLSLETR----------LRDCM   194
Noelin 2_v1   R----EEVRNLSGSLAAIQEEMGAY-----GYEDLQQRVMALEAR----------LHACA   190
Myocilin      RRGQCPQTRDTARAVPPGSREVSTWNLDTLAFQELKSELTEVPASRILKESPSGYLRSGE   240
              :     : :: :  :   ..*:.::      :::*:..:  :             *:
Noelin l_v1   QKLACGKLTGISDPVTVKTSG---SRFGSWMTDP--LAPEGDNRVWYMDGY-HNNRFVRE   258
Noelin 3_v1   KKLTCGKLMKITGPVTVKTSG---TRFGAWMTDP--LASEKNNRVWYMDSY-TNNKIVRE   248
Noelin 2_v1   QKLGCGKLTGVSNPITVRAMG---SRFGSWMTDT--MAPSADSRVWYMDGY-YKGRRVLE   244
Myocilin      GDTGCGELVWVGEPLTLRTAETITGKYGVWMRDPKPTYPYTQETTWRIDTVGTDVRQVFE   300
               .  **:*  :  *:*:::      ::* ** *.    .  :. .* :*    . : * *
Noelin l_v1   YKSMVDFMNTDNFTSHRLPHPWSGTGQVVYNGSIYFNKFQSHIIIRFDLKTETILKTRSL   318
Noelin 3_v1   YKSIADFVSGAESRTYNLPFKWAGTNHVVYNGSLYFNKYQSNIIIKYSFDMGRVLAQRSL   308
Noelin 2_v1   FRTLGDFIKGQNFIQHLLPQPWAGTGHVVYNGSLFYNKYQSNVVVKYHFRSRSVLVQRLS   304
Myocilin      YDLISQFMQGYPSKVHILPRPLESTGAVVYSGSLYFQGAESRTVIRYELNTETVEAEKEI   360
              :  : :*:.      : **    .*. ***.**::::  :*. :::: :    :   : :
Noelin l_v1   DYAGYNNMYHYAWGGHSDIDLMVDESGLWAVYATNQNAGNIVVSRLDPVSLQTLQTWNTS   378
Noelin 3_v1   EYAGFHNVYPYTWGGFSDIDLMADEIGLWAVYATNQNAGNIVISQLNQDTLEVMKSWSTG   368
Noelin 2_v1   PGAGYNNTFPYSWGGFSDMDFMVDESGLWAVYTTNQNAGNIVVSRLDPHTLEVMRSWDTG   364
Myocilin      PGAGYHGQFPYSWGGYTDIDLAVDEAGLWVIYSTDEAKGAIVLSKLNPENLELEQTWETN   420
                **::. : *:***.:*:*: .** ***.:*:*::  * **:*:*:  .*:  ::*.*.
Noelin l_v1   YPKRSAGEAFIICGTLYVTNGYSGG-TKVHYAYQTNASTYEYIDIPFQNKYSHISMLDYN   437
Noelin 3_v1   YPKRSAGESFMICGTLYVTNSHLTG-AKVYYSYSTKTSTYEYTDIPFHNQYFHISMLDYN   427
Noelin 2_v1   YPKRSAGEAFMICGVLYVTNSHLAG-AKVYFAYFTNTSSYEYTDVPFHNQYSHISMLDYN   423
Myocilin      IRKQSVANAFIICGTLYTVSSYTSADATVNFAYDTGTGISKTLTIPFKNRYKYSSMIDYN   480
                *:*..::*:***.**....:  . :.* ::* * :.  :   :**:*:* : **:***
Noelin l_v1   PKDRALYAWNNGHQILYNVTLFHVIRSDEL-                                467
Noelin 3_v1   ARDRALYAWNNGHQVLFNVTLFHIIKTEDDT                                458
Noelin 2_v1   PRERALYTWNNGHQVLYNVTLFHVISTSGDP                                454
Myocilin      PLEKKLFAWDNLNMVTYDIKLSKM-------                                504
Figure 1. Comparison of the primary sequence of noelin 1_v1, noelin 2_v1, noelin 3_v1, and myocilin.  The comparison between protein
sequences was done using the ClustalW alignment tool. Between these sequences the identical, conserved, and semi-conserved residues are
represented by asterisk, colon, and single dots, respectively. The locations of the splice junctions in the genes are marked in red. Inter-codon
and intra-codon splice junctions are indicated by marking two letters and a single letter, respectively. Within three Noelin gene products all
splice junctions, excepting the first one, were conserved. The location of the second and last splice junction of Myocilin coincides with the fifth
splice junctions of the noelin splice variants shown in the illustration.
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ing to noelin 2_v1, all others are incomplete entries (do not
have stop codons). Similar errors were also observed for noelin
3. Hence, for this study, analysis of gene structure and usage
of different exons in the splice variants were done manually
as mentioned above.
Search of the human EST database for the expression
pattern of Noelin genes:  A qualitative estimation for the ex-
pression of the Noelin genes in the eye and brain was under-
taken by a search of the human EST database using cDNAs of
different splice variants of the genes as “query” sequence. To
make sure that estimation of the expression of a targeted splice
variant was not influenced by overlapping sequence of other
splice-variants, only those ESTs with an e-value (expect value)
of 0.0 in the BLASTn analysis were taken. It is worthwhile to
mention here that we looked for information on expression
patterns of genes of interest in the corresponding GeneCards.
Contrary to our search result from the EST database the
GeneCards for Noelin 1 and Myocilin genes did not have any
information on expression of them in the eye. Hence we
searched the NCBI human EST database database to retrieve
the maximum information available regarding expression of
genes of interest. Since we were interested also to examine
expression of these genes in specific tissues of the eye, we
also searched the databases at NEIBank by NEIBLAST.
RESULTS
Identification of “myocilin related” proteins:  Myocilin
(NP_000252) was used as a query to search for proteins, which
were highly homologous to it from the NCBI database by
BLASTp [28]. On the basis of homology to N- and C-termini
of myocilin, three groups of proteins were selected under the
following names; (a) Olfactomedin 1/Noelin 1 and Pancortin
isoforms; (b) Noelin 2; and (c) Noelin 3 isoforms (Table 1).
A preliminary search of the human EST database, using
the available cDNAs corresponding to these “myocilin related”
proteins as query, suggested the expression of Noelin 1 and
Noelin 2 in eye tissues. No human EST from eye origin was
identified for Noelin 3. The results were also consistent when
we searched against transcripts of the eye in NEIBank taking
different isoforms of Noelin 1, Noelin 2, and Noelin 3 as query.
Detailed analysis of the EST database is provided later in this
section.
Homology between noelin 1, noelin 2, noelin 3, and
myocilin:  Among the isoforms of each of the three noelins,
those containing the conserved C-terminal olfactomedin do-
main and having at least 30% identity with myocilin were used
for comparison (Table 2). Three larger isoforms of Noelin 1
(noelin 1_v1, noelin 1_v2, and noelin 1_v3) and two of Noelin
3 (noelin 3_v1 and noelin 3_v2), that differed at the N-termini
by only the 5' end exons (Table 1), had a similar homology
with myocilin (data not shown). Hence, as an example, ho-
mology between noelin 1_v1, noelin 2_v1, noelin 3_v1, and
myocilin is shown in Table 2. It was observed that there was a
higher level of identity (59-64%) between noelin 1_v1, noelin
2_v1, and noelin 3_v1 with no gap required for the alignment.
Among these three proteins, noelin 1_v1 and noelin 3_v1 have
a slightly higher level of identity (64%) compared to other
combinations (59-61%). On the other hand, myocilin
(NP_000252, 504 aa) has a much lower level of identity (30-
32%) with the other 3 proteins and requires insertion of a gap
(6-13%) to maximize homology (Table 2). As shown in Fig-
ure 1, multiple alignment of noelin 1_v1, noelin 2_v1, noelin
3_v1, and myocilin by ClustalW revealed that C-termini con-
taining olfactomedin domains had much higher homology
compared to the N-termini.
To examine the evolutionary relationship between these
proteins, phylogenetic analysis was done using the primary
sequences of these proteins (Figure 2). Thus, a neighbor-join-
ing tree constructed using the entire sequence of the proteins
suggests that noelin 1_v1 and noelin 3_v1 are closely related
and these two proteins, along with noelin 2_v1 and myocilin,
evolved from the same root. To further investigate the mo-
lecular evolution of these proteins, the structure of the genes
needed to be characterized.
Structure of the Noelin 1 gene:  Five different isoforms
of Noelin 1 were identified among which only four had cDNA
submissions in the database (Table 1). The genomic contig
(NT_019501) for Noelin 1, located at 9q34.3, was retrieved
from the NCBI database and used for pairwise BLAST against
each cDNA mentioned above. The locations of the exons in
the gene containing the coding sequence represented by each
cDNA were identified and boundaries of intervening sequences
(introns) flanked by GT and AG at the 5' and 3' ends, respec-
tively, were delineated (Figure 3A). It was observed that, ex-
cept for the first 50 amino acids, noelin 1_v3, without any
cDNA entry in the database, had complete identity with noelin
1_v1. It was also observed that this stretch of 50 amino acids
of noelin 1_v1 at the N-terminal had 89% identity with the
first 53 residues of noelin 1_v3 allowing for gaps in the align-
ment. Based on this information and by inspecting the genomic
contig sequence mentioned above, the region of the genome
coding for the 50 residues of noelin 1_v1 was identified. Thus,
the Noelin 1 gene (BK001427) was found to contain a total of
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Figure 2. Phylogenetic analysis of “myocilin related” proteins.
Phylogram of human noelins and myocilin is shown. Since the level
of homology between these proteins is significant, a phylogenetic
analysis has been done to assess their evolutionary relationship, us-
ing the entire protein sequence. The scale denotes the branch length
corresponding to substitutions per site. Trichotomy means that the
tree is divided into three branches and the number 619 denotes the
bootstrap value [41].
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ten exons covering 45 kb of genomic DNA, and up to six ex-
ons were used by any particular splice variant as shown in
Figure 3A. It was interesting to note that the fourth and last
exon used in noelin 1_v4 contained only single codon and the
remaining nucleotides represented untranslated regions.
Structure of the Noelin 2 gene:  The gene structure of
Noelin 2 was determined by pairwise BLAST of the only cDNA
(NM_058164) available for the gene with the retrieved ge-
nomic contig (NT_011295) located at 19p13.2. The coding
sequence of Noelin 2 was observed to be divided into 6 exons
spanning 82 kb of the genomic sequence (BK001428, Figure
3C).
Structure of Noelin 3 gene:  For each cDNA of six differ-
ent isoforms of Noelin 3 (Table 1), pairwise BLAST searches
were done against the retrieved genomic sequence at 1p22
(NT_028050, corresponding to OLFM3). The locations of the
exons in the gene (BK001429) containing the coding sequence
represented by each cDNA and the introns were identified as
mentioned above (Figure 3B). It was interesting to note that
six splice variants could be divided into two subgroups based
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Figure 3. Structure of “myocilin re-
lated” genes and alternate usage of
exons.  Sizes of exons and introns
of Noelin 1 (A), Noelin 3 (B), Noelin
2 (C) and Myocilin (D) genes are
shown at the top of each panel. Ex-
ons are numbered from the 5' to 3'
direction. Usage of different exons
in the splice variants is shown be-
low the structures of the respective
genes. The black and white areas
within the exons denote coding se-
quences and untranslated regions
(UTRs), respectively. The number of
nucleotides used for coding amino
acids in any exon that also contains
an UTR has been given in parenthe-
sis above the exon-symbol. Exons
not completely characterized at the
5' end are shown by broken symbols
(e.g., exon 4 of Noelin 1 and exon 3
of Noelin 3). Complete or partial se-
quence of the terminal triplet codons
of the exons at splice junctions and
the corresponding amino acids are
shown. For example, where intron
sequence in the gene is present
within a triplet codon, the nucle-
otides of the codon as distributed be-
tween adjacent exons are shown. All
three Noelins contain 5 common ex-
ons (exon numbers 5, 6, and 8-10 in
Noelin 1; 4-6 and 8-9 in Noelin 3;
and 2-6 in Noelin 2) which are indi-
cated by different patterns. Each of
these 5 exons (denoted by a specific
pattern) is similar in size and/or the
terminal codons in all 3 Noelins. The
sizes of the genes, cDNA of the
splice variants of each gene and the
number of amino acids in the corre-
sponding isoforms are shown, as ap-
propriate, in the right side of the il-
lustration. The names of the differ-
ent isoforms have been given ac-
cording to the recommendations of
Human Genome Organization.
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on the gene product, the longer forms (383-478 aa) and the
shorter forms (140-235 aa), each consisting of 3 proteins. The
members of both the subgroups contained a non-homologous
stretch of amino acids at the N-termini gained by the usage of
unique exons. The frame for translation did not alter due to
the usage of different exons since in every case the first inter-
vening sequence split the coding sequence, not within, but
between adjacent codons at the splice junction. The splice
variants (noelin 3_v4, noelin 3_v5, and noelin 3_v6), which
were predicted to code for shorter proteins, contained se-
quences from an internal exon (number 7) that would code for
18 amino acids followed by a codon for the termination of
translation resulting in the elimination of the entire
olfactomedin domain from the gene product.
Molecular evolution of noelin 1, noelin 2, noelin 3, and
myocilin:  A comparison of the structures of the Noelin genes
shows striking similarities: (a) Some of the exons at compa-
rable locations within the genes have similar sizes (Figure 3).
(b) Introns split the coding sequences between two adjacent
codons at all splice junctions except one, at the 3' region of
the genes where two adjacent exons share one triplet codon
separated by the intervening intron between them. (c) Adja-
cent pairs of codons intervened by the last introns of 3 Noelin
genes encode for the same pair of amino acids (i.e., arginine
and valine). Conservation of the sizes of the exons and the
splice frames provided compelling evidence that the 3 Noelin
genes evolved by gene duplication.
Comparison of Xenopus noelin with 3 human noelins (i.e.,
noelin 1_v1, noelin 2_v1, and noelin 3_v1), it was found that
human noelin 1_v1 demonstrated the highest homology (92%
identity as compared to 59-64% for other proteins). This ob-
servation suggested that, among mammalian Noelin genes,
Noelin 1 originally evolved from its ancestral precursor gene.
Hence, within the mammalian lineage, Noelin 2 and Noelin 3
must have evolved from Noelin 1 by gene duplication. It was
further observed that the N-terminal region of noelin 1_v1 (1-
209 amino acids) had 69% and 77% homology with the corre-
sponding regions of noelin 2_v1 (1-195 amino acids) and
noelin 3_v1 (1-199 amino acids), with 3 and zero gaps re-
quired for alignment. On the other hand, the more conserved
olfactomedin domain located in the C-terminal region of noelin
1_v1 (210-467 amino acids) had a similar level of homology
(81-82%) with both noelin 2_v1 (196-454 amino acids) and
noelin 3_v1 (200-458 amino acids) with no gaps required for
the best alignment. It is noteworthy that the terminal codons
of all internal exons are highly conserved between Noelin 2
and Noelin 3 (Figure 3).
The comparison of myocilin (amino acid numbers 246-
502) with the noelins at the C-terminal region (harboring the
olfactomedin domain) showed a similar level (60-61%) of
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Figure 4. Comparison of gene structure of Noelin 2 and Myocilin.  The sizes of the exons of both the genes and the number of amino acids
encoded by those are shown. Exons of Noelin 2 used in noelin 2_v1 and predicted to have been fused in Myocilin during evolution are
indicated. The total number of nucleotides within these sets of exons for the genes, number of nucleotides in the coding sequence (in parenthe-
sis), and number of amino acids coded by the exon(s) are shown. The codon split by intron 4 of Noelin 2 and the terminal bases for the codons
at the 3' end of exon 1 and 5' end of exon 3 of Myocilin are indicated. Five of the six exons of Noelin 2 sharing similar features with other 2
Noelin genes are represented by bolded square. The protein domains encoded by Noelin 2 and myocilin are marked.
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homology but the N-terminal region did not show any signifi-
cant homology as judged by BLASTp results. However, a
manual comparison of the same region of myocilin (amino
acid numbers 1-201) revealed that it had a higher level of iden-
tity with noelin 2_v1 (46 aa) relative to noelin 1_v1 (33 aa)
and noelin 3_v1 (29 aa). It is interesting to note that the ge-
nomic region of Noelin 2 and Myocilin encoding for a myo-
sin-like coiled-coil structure at the N-terminal region of the
proteins are divided into 4 exons (numbers 1-4) in the former
but contained in a single exon in the latter gene. Similarly, the
genomic region of Noelin 2 encoding an olfactomedin-like
domain is split into two exons (numbers 5 and 6) while the
corresponding genomic region of Myocilin encoding for the
same protein domain is represented by a single exon. Also,
the number of amino acids encoded by both the genes for this
region is 261 (Figure 4). The last nucleotide (G) of both exon
4 of Noelin 2 and exon 1 of Myocilin represents the first base
of a codon. Similarly, the first two nucleotides of exon 5 of
Noelin 2 (GC) and exon 3 of Myocilin (GA) represent the sec-
ond and third bases of a codon. If exons 1 and 3 of Myocilin
were spliced together, the same amino acid (glycine) would
have been coded at the junction as for the splicing of exon 4
and 5 of Noelin 2. Based on these observations, we propose
that Myocilin has most likely evolved from Noelin 2 by gene
duplication and exon fusion (Figure 5).
Expression profile of Noelins based on EST database:
After searching the literature for experimental data on expres-
sion of Noelin genes in human, little information was found.
Originally, expression of Noelin 3 in the human retina, trabe-
cular meshwork cells, and brain has been claimed based on
RT-PCR [21]. Recently, the same group reported Noelin 1 and
Noelin 2 expression in the human retina and brain using the
same technique [9]. Among other species, the expression of
Noelin 1 in the neural crest, cranial ganglia, and brain of
xenopus, chicken, and mouse has been reported [29]. In the
rat, the gene was reported to be expressed in the brain and eye
[21]. Noelin 3 expression in retina and brain of rats has been
shown by northern analysis. Due to a paucity of the expres-
sion data on human Noelin genes, we searched the human EST
database as described above (Methods). From the collated data
set from human EST hits, it appears that all known Noelin 1
splice variants and Noelin 2 expression occurred primarily in
the brain and eye, while the Noelin 3 expression was evident
in the brain and other tissues but not in the eye (Table 3). The
data only provides a qualitative assessment regarding the ex-
pression of Noelin genes despite a variable number of clones
in Table 3 because the ESTs in the database represent a collec-
tion of data from non-uniform heterogeneous sources. We
searched the NEIBank repository of EST data to identify tis-
sue specific expression of the Noelin genes within the eye,
and retrieved one transcript from both retina and choroid cor-
responding to Noelin 1 (i.e., Noelin 1_v1, Noelin 1_v2, and
Noelin 1_v3). The present status of the database limits the
scope of investigation to any further depth. Nevertheless, such
in silico approaches have the potential to provide a priori in-
formation regarding the status of expression which must be
tested and confirmed by wet-lab experiments.
Possible functional implications of noelins in the eye and
its pathogenesis:  It is interesting to note that among the
olfactomedin-like proteins, in addition to myocilin, at least
two Noelins (Noelin 1 and Noelin 2) are expressed in the eye
though the reported expression of Noelin 3 in the eye needs to
be re-examined. It has been demonstrated by in vitro experi-
ments that myocilin forms a homodimer through its leucine
zipper domain [30] and a heterodimer with noelin 3 (optimedin)
by interaction through the olfactomedin domains [21]. The
olfactomedin regions between the 3 Noelin gene products have
high levels of homology (79-82%). Hence, it is reasonable to
predict that myocilin is likely to interact in vivo with the noelin
1 and noelin 2 isoforms through the olfactomedin domains
provided that the interacting genes are expressed in the same
location. Such interaction may have functional implications
and/or pathology related to the aberration of such interactions.
However, experimental evidence for co-expression of Myocilin
and Noelins in the same ocular tissue in human is needed.
DISCUSSION
 Myocilin, a mammalian olfactomedin-like protein, is ex-
pressed in the trabecular meshwork of the eye and when de-
fective causes primary open angle glaucoma (POAG). The
biological function of myocilin is not well understood. The
natural null mutant in humans does not show POAG [31] and
the myocilin knock-out mouse does not have eye related prob-
lems [32]. The dominant transmission of POAG in families
with mutant myocilin suggests a gain of function of the defec-
tive protein. Human myocilin bears the highest level of ho-
mology with the Xenopus noelin, which is also an
olfactomedin-like protein, among sub-mammalian species
[20]. It has been reported (based on in situ hybridization) that
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Figure 5. Evolution of “myocilin related” proteins.  A proposed evo-
lution of the proteins in the multigene family from the noelin precur-
sor molecule in sub-mammalian species has been shown. The possi-
bility of evolution of myocilin from any of the three noelins has been
indicated by dotted lines and arrows, with wider arrow from noelin 2
to suggest it as the most likely immediate precursor molecule.
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XenopusNoelin is expressed only in post-mitotic neural tis-
sues, the cranial ganglia, eye, and neural tube [29]. A recent
report predicted that optimedin (noelin 3), another
olfactomedin domain containing protein with homology to
myocilin, could be involved in pathogenesis of ocular disor-
ders based on its expression in the mammalian (rat and hu-
man) eye and its interaction with myocilin [21]. Thus, we rea-
soned that it is likely that other “myocilin related” proteins
might exist, which when defective will lead to pathology within
the eye either singly or through interaction with other related
proteins. The identification of three such groups of proteins,
by database search including noelin 3, with homology to
myocilin under various names was confusing to relate to, and
to study evolution, expression, and functional implication of
these proteins. Thus we have proposed a systematic use of
existing nomenclatures based on characterization of the pro-
teins as splice variants of three different genes, following the
guidelines of HUGO.
Determination of the structure of the genes and a detailed
analysis of the splice junction sequences helped to sort the
most likely route of molecular evolution of these proteins. It
is intriguing to note that two Noelin genes (Noelin 1 and Noelin
3) have multiple splice variants, but no splice variant is yet
known for Noelin 2. It is noteworthy that our effort to find
such gene products from the EST database did not result in
any hits. However, AceView at the NCBI server includes a
Noelin 2 isoform, which is an incomplete submission missing
the complete C-terminus of the protein, hence it is not listed
in Table 1. Comparison of this noelin 2 isoform with noelin 1
and noelin 3 proteins suggests that the full-length isoform of
noelin 2 is homologous to noelin 1_v2 and noelin 3_v2 (data
not shown). Since the only Noelin 2 protein identified so far
has both structural and sequence homology with Noelin 1_v1
and Noelin 3_v1 among all other variants, we intend to iden-
tify Noelin 2 as Noelin 2_v1 for proper nomenclature of yet
unidentified other splice variants (if any) of the gene. It has
been proposed that extensive modification of the N-terminal
half and the acquisition of a C-terminal SDEL endoplasmic-
reticulum-targeting sequence may have enabled olfactomedin
to adopt new functions in the mammalian central nervous sys-
tem [12]. The identification of a large number of splice-vari-
ants for both Noelin and Noelin 3 and the expression of these
variants at the RNA level should lead to experiments to iden-
tify these proteins in the brain and decipher their functional
role in the neural network.
While gene duplication is a well-known means for the
creation of a multigene family, and fusion of exons is known
to be responsible for creation of splice variants and
pseudogenes, the proposed fusion of exons for the evolution
of Myocilin from its precursor is not yet a described mecha-
nism of gene evolution in the literature, to the best of our
knowledge. However, the fusion of two proteins encoded by
two different genes in lower organisms to a single product
encoded by a single gene in higher organisms has been re-
ported [33]. One example among many is the fusion of two E.
coli proteins (γ-glutamyl phosphate reductase and glutamate
5-kinase) to a single human protein (δ-1-pyrroline-5-carboxy-
late synthetase).
Experimental evidence for the expression of Noelin genes
in neuronal tissues in the amphibia, chicken, rat, and mouse is
consistent with the expression pattern of Noelin in human as
revealed by EST database analysis. Interestingly, the reported
expression of Noelin 3 in the human eye is not supported by
the EST data available at both NCBI and NEI databases. Fur-
ther, we attempted to examine tissue specific expression of
Noelin in the eye by searching the NEIBank EST database.
However, this strategy did not reveal much new information.
We predict that the tissue specific dataset at the NEIBank is
not yet large enough to include genes not expressed at high
level. To test this possibility, we looked in the NEIBank for
ESTs of the genes that are expressed in retinal photoreceptor
cells and which cause retinal diseases when defective. How-
ever, we did not find significant hits for many of these genes
in the retinal database (NEI human retina unnormalized). The
elegant experiments done to show in vitro that noelin 3_v1
forms a heterodimer with myocilin through the interaction of
the olfactomedin domains of these two proteins is interesting.
The olfatomedin domain of myocilin has a similar level of
homology (60%) with the protein domain in all 3 noelins.
Hence, it is reasonable to hypothesize that myocilin will also
make heterodimers with noelin 1_v1 and noelin 2_v1 inde-
pendently, which need to be tested first by in vitro experi-
ments. The expression of Noelin 1 and Noelin 2 in the eye and
the possibility of interaction of both gene products with
myocilin raises the real possibility that these two genes might
be candidates for eye diseases. In mammals, noelin has been
found in the neural plate and neural crest, as well as in the
cranial ganglia. It is also known that the developmental anoma-
lies that are frequently associated with glaucoma are mainly
caused by the abnormal differentiation of neural crest cells
[34]. Further support for the hypothesis comes from the re-
ported similar chromosomal location (9q34) of Noelin 1 and
LMX1B genes. LMX1B has been implicated in causing nail-
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TABLE 3. EXPRESSION OF NOELIN GENES IN THE BRAIN AND EYE
                           Accession number      ESTs selected (e=0)
                         ---------------------   --------------------
  Gene      Protein       Protein      cDNA      Eye   Brain   Others   Total
--------   ----------    ---------   ---------   ---   -----   ------   -----
Noelin 1   noelin 1_v1   NP_055094   NM_014279   16     72       24      112
           Noelin 1_v2   BAC04756    AK096304    10     64       21       95
           Noelin 1_v3   Q99784      N/A         11     70       19      100
           Noelin 1_v4   NP_006325   NM_006334   12     20        -       32
           Noelin 1_v5   NP_478106   NM_058199    9      5       15       29
Noelin 2   noelin 2_v1   NP_477512   NM_058164    6     33       21       60
Noelin 3   noelin 3_v1   AAK97475    AF397394     -      7        2        9
           Noelin 3_v2   AAK97473    AF397392     -      6        3        9
           Noelin 3_v3   AAK97477    AF397396     -      6        4       10
           Noelin 3_v4   AAK97476    AF397395     -      7        2        9
           Noelin 3_v5   AAK97474    AF397393     -      6        3        9
           Noelin 3_v6   AAK97478    AF397397     -      6        4       10
The ESTs that gave zero e-value (expect value) in BLAST were se-
lected to ensure that they truly represented the expression of the query
splice variant. The data have only been used for qualitative assess-
ment regarding the expression of the Noelin genes despite variable
number of clones since the source of the ESTs in the database are
from heterogeneous cDNA libraries. ESTs under the “Others” col-
umn include dorsal root ganglia, embryo, cervix, sympathetic trunk,
lung, placenta, prostate, and other pooled tissues as the mRNA source.
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patella syndrome, a developmental anomaly that co-segregates
with open angle glaucoma in some families.
Unlike retinitis pigmentosa (RP), other eye diseases are
mostly sporadic with the plausible effects of multiple genetic
loci and environments. Despite the limited transmission of
POAG in families following monogenic traits due to six iden-
tified loci [35-40], it is largely sporadic and is transmitted as a
complex disease with no knowledge of any biochemical path-
way to choose candidate genes from. The identification and
inclusion of the new genes in the repertoire of the candidates
for eye diseases provides the opportunity to test these genes
for the causation of monogenic disorders. On the other hand,
the identification of single nucleotide polymorphism (SNP)
patterns in these genes from patients showing complex forms
of the disease followed by association studies might shed new
light in the understanding of common but more challenging
eye disorders. Computational analysis done by data mining
and presented in this article provides an opportunity to test
new hypotheses by wet-lab experiments that are directly re-
lated to the deciphering of human genetic diseases.
In summary, the major observations in this manuscript
not previously described are: (a) A complete characterization
of the genes for three olfactomedin related proteins which have
been specifically selected on the basis of high homology with
myocilin. (b) Identification of all possible splice variants of
these 3 genes. (c) Evolutionary relatedness between these 3
genes at the molecular level as revealed by the analysis of the
splice junctions and splice variants of these 3 genes. (d) Quali-
tative assessment regarding expression of different splice vari-
ants of the genes available in the EST database.
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